Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Clinical trial NCT00892177 · COMPLETED
Trial details
- NCT number
- NCT00892177
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2014-11-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.